Breast Cancer Res Treat. 2010 Jun 11.
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
http://www.ncbi.nlm.nih.gov:80/pubmed/20544271
Wednesday, June 16, 2010
China: Disease Control and Prevention of Shenzhen_ATM C. 1066-6T biomarker for breast cancer under scrutinizing
Labels:
China Technology
Subscribe to:
Post Comments (Atom)
alveice Team. Powered by Blogger.
No comments:
Post a Comment